THE EFFECTIVENESS OF PSYCHOTHERAPY ALONE AND IN CONJUNCTION WITH PERPHENAZINE OR PLACEBO IN THE TREATMENT OF NEUROTIC AND HYPERKINETIC CHILDREN
Abstract
Pediatric patients with neurotic and hyperkinetic reaction patterns have been treated experimentally on one of 3 schedules: (a) brief psychotherapy, (b) brief psychotherapy plus placebo, (c) brief psychotherapy plus perphenazine. Analysis of the clinical response rates has led us to the following conclusions:
1. Children with neurotic symptomatology show a prompt and enduring response to a brief program of psychotherapy at a level of improvement (60-70%) that is significantly greater than that attained by children with hyperkinetic syndromes (15-40%).
2. No evidence was obtained for any enhancement of the response to brief psychotherapy from the addition of placebo medication.
3. We were unable to demonstrate a significant difference between response to placebo and to perphenazine when administered concomitantly with psychotherapy.
The implications of these findings have been discussed.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
